Some 60-count cartons of clonazepam orally disintegrating 0.25 milligram tablets might be incorrectly labeled as 0.125 milligram tablets. Blister strips inside the package reflect the correct strength, the agency said.
Endo is advising customers to discontinue use of the product, which could cause significant sedation, ataxia or respiratory depression if the wrong dosage is consumed.
Zero adverse events have been reported.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.